HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Non-dystrophic myotonia Chilean cohort with predominance of the SCN4A Gly1306Glu variant.

Abstract
Non-dystrophic myotonias are a group of rare neuromuscular diseases linked to SCN4A or CLCN1. Among the subtypes, myotonia permanens, associated with the Gly1306Glu variant of SCN4A, is a relatively less frequent but more severe form. Most reports of non-dystrophic myotonias describe European populations. Therefore, to expand the genetic and phenotypic spectrum of this disorder, we evaluated 30 Chilean patients with non-dystrophic myotonias for associated variants and clinical characteristics. SCN4A variants were observed in 28 (93%) of patients, including 25 (83%) with myotonia permanens due to the Gly1306Glu variant. Myotonia permanens was inherited in 24 (96%) patients; the mean age of onset was 6 months, and the initial symptoms were orbicularis oculi myotonia in 17 (74%) patients and larynx myotonia in 12 (52%) patients. The extraocular muscles were involved in 11 (44%) patients, upper limbs in 20 (80%), and lower limbs in 21 (84%). Thirteen (52%) patients experienced recurrent pain and 10 (40%) patients reported limitations in daily life activities. Carbamazepine reduced myotonia in eight treated patients. The high frequency of the Gly1306Glu variant in SCN4A in Chilean patients suggests a founder effect and expands its phenotypic spectrum.
AuthorsDaniela Avila-Smirnow, Carmen Paz Vargas Leal, María de Los Angeles Beytía Reyes, Rocío Cortés Zepeda, Raúl G Escobar, Karin Kleinsteuber Saa, Marcela Lagos Lucero, María de Los Angeles Avaria Benapres, Oslando Padilla Pérez, Juan Carlos Casar Leturia, Cecilia Mellado Sagredo, Damien Sternberg
JournalNeuromuscular disorders : NMD (Neuromuscul Disord) Vol. 30 Issue 7 Pg. 554-561 (07 2020) ISSN: 1873-2364 [Electronic] England
PMID32593548 (Publication Type: Journal Article)
CopyrightCopyright © 2020 Elsevier B.V. All rights reserved.
Chemical References
  • NAV1.4 Voltage-Gated Sodium Channel
  • SCN4A protein, human
Topics
  • Adolescent
  • Adult
  • Child
  • Chile
  • Cohort Studies
  • Female
  • Founder Effect
  • Humans
  • Infant
  • Male
  • Mutation
  • Myotonia (genetics)
  • Myotonic Disorders (genetics)
  • NAV1.4 Voltage-Gated Sodium Channel (genetics)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: